Literature DB >> 10570427

Adenovirus-mediated E2F-1 gene transfer efficiently induces apoptosis in melanoma cells.

Y B Dong1, H L Yang, M J Elliott, T J Liu, A Stilwell, C Atienza, K M McMasters.   

Abstract

BACKGROUND: E2F-1 is a transcription factor that stimulates cellular proliferation and cell cycle progression from G(1) to S-phase. Somewhat paradoxically, E2F-1 also has the properties of a tumor suppressor. Overexpression of E2F-1 has been shown to induce apoptosis in some cancer cells. In the current study, the effect of adenovirus-mediated E2F-1 gene transfer on human melanoma cell growth was investigated.
METHODS: Two human melanoma cell lines, SK-MEL-28 (wild-type p53) and SK-MEL-2 (mutant p53), were treated by mock infection, infection with a control vector expressing the beta-galactosidase gene (Ad5CMV-LacZ), or infection with a vector expressing E2F-1 (Ad5CMV-E2F-1) at a multiplicity of infection of 100. Cell proliferation and viability were determined by WST-1 assay and trypan blue exclusion, respectively. Apoptosis was assessed by cell flow cytometry and confirmed by cell morphology, in situ terminal deoxynucleotidyl nick end labeling assay, and poly(ADP-ribose) polymerase cleavage assay.
RESULTS: Marked overexpression of E2F-1 was evident in both cell lines 24 hours after infection with Ad5CMVE2F-1 by Western blot analysis. E2F-1 overexpression resulted in growth inhibition and rapid loss of cell viability. Overexpression of E2F-1 also resulted in premature S-phase entry and G(2) arrest at 24 hours followed by apoptotic cell death at 48 hours. After Ad5CMVE2F-1 infection, expression of Bax and Bak was unchanged, whereas Mcl-1 levels decreased markedly. In SK-MEL-28 cells, Bcl-XL levels also declined after E2F-1 expression. Bcl-2 was undetectable in SK-MEL-28 cells but was increased in SK-MEL-2 cells in response to E2F-1 overexpression.
CONCLUSIONS: Adenovirus-mediated E2F-1 gene transfer efficiently induces widespread apoptosis in human melanoma cells. E2F-1 overexpression induced apoptosis in cell lines containing wild-type and mutant p53, suggesting that this effect does not require wild-type p53 function. Anti-apoptotic proteins of the Bcl-2 family, notably Mcl-1 and Bcl-XL, may be involved in mediating the response to E2F-1. These data suggest that adenovirus-mediated E2F-1 gene therapy may be effective in the treatment of melanoma. Copyright 1999 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570427     DOI: 10.1002/(sici)1097-0142(19991115)86:10<2021::aid-cncr20>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Prognostic value of E2F1 in rectal cancer.

Authors:  Hasan Uzer; Hızır Akyıldız; Erdoğan Sözüer; Alper Akcan; Bahadır Öz
Journal:  Turk J Surg       Date:  2017-09-01

2.  Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus.

Authors:  Jorge G Gomez-Gutierrez; Xiao-Mei Rao; Heshan Sam Zhou; Kelly M McMasters
Journal:  Virology       Date:  2012-09-27       Impact factor: 3.616

3.  Adenovirus-mediated expression of truncated E2F-1 suppresses tumor growth in vitro and in vivo.

Authors:  Jorge G Gomez-Gutierrez; Aracely Garcia-Garcia; Hongying Hao; Xiao-Mei Rao; Roberto Montes de Oca-Luna; Heshan S Zhou; Kelly M McMasters
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

4.  Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.

Authors:  Thirupandiyur S Udayakumar; Radka Stoyanova; Paul Hachem; Mansoor M Ahmed; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-01       Impact factor: 7.038

5.  E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.

Authors:  Wei-Yuan Wei; Lin-Hai Yan; Xiao-Tong Wang; Lei Li; Wen-Long Cao; Xiao-Shi Zhang; Ze-Xu Zhan; Han Yu; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

6.  Developing adenoviral vectors encoding therapeutic genes toxic to host cells: comparing binary and single-inducible vectors expressing truncated E2F-1.

Authors:  Jorge G Gomez-Gutierrez; Xiao-Mei Rao; Aracely Garcia-Garcia; Hongying Hao; Kelly M McMasters; H Sam Zhou
Journal:  Virology       Date:  2009-12-08       Impact factor: 3.616

7.  MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway.

Authors:  Surovi Hazarika; Charles R Farber; Ayotunde O Dokun; Achillieas N Pitsillides; Tao Wang; R John Lye; Brian H Annex
Journal:  Circulation       Date:  2013-04-04       Impact factor: 29.690

8.  Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms.

Authors:  Francesca Nicolau-Galmés; Aintzane Asumendi; Erika Alonso-Tejerina; Gorka Pérez-Yarza; Shawkat-Muhialdin Jangi; Jesús Gardeazabal; Yoana Arroyo-Berdugo; Jesús María Careaga; Jose Luís Díaz-Ramón; Aintzane Apraiz; María D Boyano
Journal:  Apoptosis       Date:  2011-12       Impact factor: 4.677

9.  E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation.

Authors:  Hongying Hao; Yanbin Dong; Maria T Bowling; Jorge G Gomez-Gutierrez; H Sam Zhou; Kelly M McMasters
Journal:  BMC Cancer       Date:  2007-01-30       Impact factor: 4.430

10.  Transduction of E2F-1 TAT fusion proteins represses expression of hTERT in primary ductal breast carcinoma cell lines.

Authors:  Kimberly A Elliott; Lee F Rickords; J Marcelete Labrum
Journal:  Mol Cancer       Date:  2008-03-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.